Reference number : 236-2015-2016-Q1-00081, amendment number : , agreement type : G, recipient legal name : Lepage, Martin, recipient country : CA, recipient province : QC, recipient city : Verdun, recipient postal code : H4H 1R3, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 568337.0, agreement start date : 2015-10-01, agreement end date : 2020-09-30, description english : Aripiprazole Long Acting Injectable (ALAI), its potential enhancing effect on memory and associated neural structures: A longitudinal brain imaging study in first-episode psychosis, description french : Aripiprazole Long Acting Injectable (ALAI), its potential enhancing effect on memory and associated neural structures: A longitudinal brain imaging study in first-episode psychosis, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2015-16 to 2020-21), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2015-16 à 2020-21), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada